Vitamin D Deficiency in Human Immunodeficiency Virus

Phase 4

Completed

• Conditions: Vitamin D Deficiency; Human Immundeficiency Infection; Diet and Nutrition - Other diet and nutrition disorders; Infection - Acquired immune deficiency syndrome (AIDS / HIV)

• Registration Number: ACTRN12611000631909
• Lead Sponsor: The Alfred Hospital Research Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2011-05-18
• Study Start: 2011-06-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Documented HIV infection
Age greater than 18 years
Vitamin D deficiency (<50 nmol/l)

Exclusion Criteria

Pregnancy
On vitamin D supplementation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of Human Immunodeifiency Virus (HIV) patients who achieve normal Vitamin D levels (>50 nmol/l) measured by blood analysis[12 months following supplementation]

Secondary Outcome Measures

Name	Time	Method
Effect of vitamin D supplementation on bone markers (Calcium, phosphate, Alkaline Phosphatase, Parathryroid Hormone) by blood assays[12 months following supplementation];Effect of vitamin D supplementation on immunological markers (CD4 lymphocyte cell counts) by blood assays[12 months following supplementation]